| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |